Embryonic Stem Cell MicroRNAs for Safe iPS Cell Reprogramming

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for generating induced pluripotent stem (iPS) cells using genetic elements like viruses risk activating oncogenes and require genetic modifications, limiting their therapeutic potential due to the risk of tumorigenesis and genetic alterations.

Innovation Solution

Introducing specific microRNAs (miRNAs) such as miR-291-3p, miR-294, and miR-295 into somatic cells to enhance pluripotency without the need for viral vectors, thereby reducing oncogene activation and creating iPS cells with minimal or no genetic modifications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If retroviral vectors are used to induce expression of four factors (Oct3/4, Sox2, c-Myc, Klf3) to generate iPS cells, then pluripotency is achieved, but oncogene activation and tumorigenesis risk increase

Engineering Contradiction:

Improvepluripotency induction efficiencyVSAvoidoncogene activation and tumorigenesis risk

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes the harmful c-Myc factor from the traditional four-factor reprogramming system. By using only Oct3/4, Sox2, and Klf3 without c-Myc, the invention eliminates the primary oncogenic risk while maintaining pluripotency induction capability, directly resolving the contradiction between efficiency and safety

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces small molecules as intermediary agents that enhance the reprogramming efficiency of the three-factor system. These small molecules act as mediators to compensate for the removal of c-Myc, maintaining high pluripotency induction efficiency without requiring the oncogenic factor

Inventive Principle:

Principle #24Intermediary (Mediator)

2Ease of manufacture

If retroviral vectors are used to introduce genetic elements, then reprogramming factors are delivered, but genetic modifications are introduced increasing therapeutic risk

Engineering Contradiction:

Improvereprogramming factor deliveryVSAvoidgenetic modifications and therapeutic risk

Core Design Contradiction:

Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical/genetic delivery system (retroviral vectors integrating DNA into the genome) with a chemical delivery system (small molecules). This substitution eliminates genetic modifications while maintaining the ability to deliver reprogramming signals, resolving the contradiction between ease of manufacture and therapeutic safety

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental parameter of delivery mechanism from genetic (DNA/RNA-based viral delivery) to chemical (small molecule-based delivery). This parameter change allows for efficient reprogramming factor delivery without permanent genetic modifications, reducing therapeutic risk

Inventive Principle:

Principle #35Parameter changes

Data Source

PatentUS9353352B2Embryonic stem cell specific microRNAs promote induced pluripotency

Publication Date: 2016.05.31 RGT UNIV OF CALIFORNIA

AI summary

The methods of the present application describe that introduction of physiologically relevant miRNAs can enhance or modulate somatic cell reprogramming, generating induced pluripotent stem cells (iPS cells). These miRNAs did not further enhance reprogramming in the presence of cMyc. Furthermore, unlike previously described methods of generating iPS cells, such as through the introduction of genetic elements using viruses, the methods of the present invention reduce the risk of activating oncogenes in the iPS cells. The methods of the invention generate iPS cells that can be free of genetic modifications and thus have greater potential for use as therapeutic agents than those generated by existing methods.